Precigen Inc (PGEN)
1.005
-0.02 (-1.47%)
USD |
NASDAQ |
Mar 30, 16:00
1.005
0.00 (0.00%)
After-Hours: 17:01
Precigen Profit Margin (Quarterly): -1.26K% for Dec. 31, 2022
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -1.26K% |
| September 30, 2022 | |
| June 30, 2022 | -605.8% |
| March 31, 2022 | -60.12% |
| December 31, 2021 | -679.5% |
| September 30, 2021 | -893.0% |
| June 30, 2021 | -525.6% |
| March 31, 2021 | -70.65% |
| December 31, 2020 | -215.5% |
| September 30, 2020 | -125.1% |
| June 30, 2020 | -142.5% |
| March 31, 2020 | -187.7% |
| December 31, 2019 | 41.73% |
| September 30, 2019 | -293.1% |
| June 30, 2019 | -118.1% |
| March 31, 2019 | -268.8% |
| December 31, 2018 | -1.01K% |
| September 30, 2018 | -176.7% |
| June 30, 2018 | -144.4% |
| March 31, 2018 | -116.4% |
| December 31, 2017 | -41.62% |
| September 30, 2017 | -86.25% |
| Date | Value |
|---|---|
| June 30, 2017 | -34.29% |
| March 31, 2017 | -58.42% |
| December 31, 2016 | -95.95% |
| September 30, 2016 | -59.17% |
| June 30, 2016 | -93.45% |
| March 31, 2016 | -148.3% |
| December 31, 2015 | -78.83% |
| September 30, 2015 | -71.60% |
| June 30, 2015 | -90.58% |
| March 31, 2015 | 80.05% |
| December 31, 2014 | 60.57% |
| September 30, 2014 | -248.7% |
| June 30, 2014 | -441.5% |
| March 31, 2014 | 52.39% |
| December 31, 2013 | -170.9% |
| September 30, 2013 | |
| June 30, 2013 | -89.13% |
| March 31, 2013 | -934.6% |
| December 31, 2012 | -475.6% |
| September 30, 2012 | -700.5% |
| June 30, 2012 | -606.6% |
| March 31, 2012 | -859.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.26K%
Minimum
Dec 2022
41.73%
Maximum
Dec 2019
-360.3%
Average
-187.7%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| Sonoma Pharmaceuticals Inc | -65.86% |
| First Wave BioPharma Inc | -- |
| Baudax Bio Inc | -2.98K% |
| Xilio Therapeutics Inc | -- |
| Abbott Laboratories | 10.24% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 28.00% |
| Return on Assets | 9.49% |
| Return on Invested Capital | 11.69% |
| Gross Profit Margin (Quarterly) | 28.70% |
| Operating Margin (Quarterly) | -1.24K% |
| Return on Net Operating Assets | 23.31% |